Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007382
Filing Date
2025-05-12
Accepted
2025-05-12 16:12:23
Documents
74
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250331x10q.htm   iXBRL 10-Q 1551320
2 EX-31.1 tmb-20250331xex31d1.htm EX-31.1 14415
3 EX-31.2 tmb-20250331xex31d2.htm EX-31.2 14453
4 EX-32.1 tmb-20250331xex32d1.htm EX-32.1 7698
5 EX-32.2 tmb-20250331xex32d2.htm EX-32.2 7766
  Complete submission text file 0001558370-25-007382.txt   6219801

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20250331.xsd EX-101.SCH 49178
7 EX-101.CAL tmb-20250331_cal.xml EX-101.CAL 45844
8 EX-101.DEF tmb-20250331_def.xml EX-101.DEF 174619
9 EX-101.LAB tmb-20250331_lab.xml EX-101.LAB 393149
10 EX-101.PRE tmb-20250331_pre.xml EX-101.PRE 319310
77 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250331x10q_htm.xml XML 854489
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 25934953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)